Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × UNKNOWN × Idarubicin × Clear all

Phase

Status

Sponsor Class

OTHER 13 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1

Interventions

toripalimab 1 pegylated granulocyte colony-stimulating factor 1 Idarubicin 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Growth Hormone 1 Cytarabine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01990807 2013-11-21

Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia

ChineseAMS

Phase 4 Unknown

LymphoidOther hematologic neoplasm

Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡